Please note: this product has been discontinued. For your convenience, the INFA, INFB and RNP ValuPanel oligonucleotides may still be ordered by email at firstname.lastname@example.org. The other oligonucleotides in this panel (sequence information below) can be obtained by placing a custom order.
The 2009 H1N1 (Novel Influenza A) ValuPanel™ Reagents* are part of LGC Biosearch Technologies’ ValuPanel line of detection reagents. ValuPanel Reagents are composed of probes and primers that resolve genetic signatures of different pathogen strains.
*For Research Use Only. Not for use in diagnostic procedures.
2009 H1N1 Signatures Licensed from the CDC**
As a licensed manufacturer of oligonucleotides to resolve 2009 H1N1 signatures, LGC Biosearch Technologies is pleased to offer the same sequences in the form of ValuPanel Reagents. This panel consists of dual-labeled BHQ probes, a forward primer, and a reverse primer for use in real-time qPCR to discriminate H1N1-related viral strains. 2009 H1N1 ValuPanel Reagents contain probes and primers based on genetic signatures for the following strains:
- Influenza A
- Swine Influenza A
- Swine H1 Influenza A
- Human RNase P (Extraction Control)
These probes are labeled with FAM and Black Hole Quencher® (BHQ®) dyes. All probes and primers are HPLC purified. LGC Biosearch is the inventor of the BHQ dyes and is the sole manufacturer of the true dark quencher currently used for the labeled probes in the 2009 H1N1 diagnostic test.
**CDC does not endorse products or services.
Responding to a Public Health Emergency
In response to the outbreak of novel 2009 H1N1, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to the CDC for the immediate use of the Real-time RT-PCR Detection Assays for 2009 H1N1 designed by the US Centers for Disease Control and Prevention (CDC). The CDC readily developed the 2009 H1N1 Panel to detect and identify cases of the novel influenza A (H1N1) virus, and is the first FDA-authorized distributor of this molecular diagnostic test to public health and other qualified laboratories. Biosearch Technologies participated in the rapid response to the Flu pandemic by supplying the probes and primers necessary for the H1N1 detection panel.
|Catalog #||Item name||Size||Sequence|
|SWH1-F-20||swH1, Swine H1 Influenza (2009 H1N1) Forward Primer||20 nmol||GTG CTA TAA ACA CCA GCC TYC CA|
|SWH1-R-20||swH1, Swine H1 Influenza (2009 H1N1) Reverse Primer||20 nmol||CGG GAT ATT CCT TAA TCC TGT RGC|
|SWH1-P-5||swH1, Swine H1 Influenza (2009 H1N1) Probe||5 nmol||FAM-CA GAA TAT ACA(T-BHQ1)CC RGT CAC AAT TGG ARA A-Spacer C3|
|SWINFA-F-20||swInfA, Swine Influenza A (2009 H1N1) Forward Primer||20 nmol||GCA CGG TCA GCA CTT ATY CTR AG|
|SWINFA-R-20||swInfA, Swine Influenza A (2009 H1N1) Reverse Primer||20 nmol||GTG RGC TGG GTT TTC ATT TGG TC|
|SWINFA-P-5||swInfA, Swine Influenza A (2009 H1N1) Probe||5 nmol||FAM-CYA CTG CAA GCC CA(T-BHQ1) ACA CAC AAG CAG GCA-Spacer C3|
|INFA-F-20||InfA, Universal Influenza A Forward Primer||20 nmol||GAC CRA TCC TGT CAC CTC TGA C|
|INFA-R-20||InfA, Universal Influenza A Reverse Primer||20 nmol||AGG GCA TTY TGG ACA AAK CGT CTA|
|INFA-P-5||InfA, Universal Influenza A Probe||5 nmol||FAM-TGC AGT CCT CGC TCA CTG GGC ACG-BHQ1|
|RNP-F-20||Human RNase P Extraction Control Forward Primer||20 nmol||AGA TTT GGA CCT GCG AGC G|
|RNP-R-20||Human RNase P Extraction Control Reverse Primer||20 nmol||GAG CGG CTG TCT CCA CAA GT|
|RNP-P-5||Human RNase P Extraction Control Probe||5 nmol||FAM-TTC TGA CCT GAA GGC TCT GCG CG-BHQ1|